Literature DB >> 23712382

Combined treatment with regulatory T cells and vascularized bone marrow transplantation creates mixed chimerism and induces donor-specific tolerance to vascularized composite allografts without cytoreductive conditioning.

Jeng-Yee Lin1, Feng-Chou Tsai, Christopher Glenn Wallace, Wei-Chao Huang, Fu-Chan Wei, Shuen-Kuei Liao.   

Abstract

We demonstrate herein that combination treatment with regulatory T cells (Tregs) and vascularized bone marrow transplantation (VBMT) can achieve stable mixed chimerism and long-term transplantation tolerance to vascularized composite allografts (VCA) without requiring cytoreductive recipient conditioning in rats. An appreciable number of Tregs of recipient origin was shown at the interface between recipient and transplanted VCA tissues, implicating a significant role for Tregs in protecting VCA from rejection. This cytoreduction-free protocol using co-treatment with Tregs and VBMT warrants further investigation toward potential clinical application for VCA transplantation.

Entities:  

Keywords:  Treg; composite tissue allograft; graft-versus-host disease; mixed chimerism; transplantation; vascularized bone marrow transplantation; vascularized composite allograft

Mesh:

Year:  2013        PMID: 23712382      PMCID: PMC3654733          DOI: 10.4161/chim.23349

Source DB:  PubMed          Journal:  Chimerism        ISSN: 1938-1964


  10 in total

1.  Actively acquired tolerance of foreign cells.

Authors:  R E BILLINGHAM; L BRENT; P B MEDAWAR
Journal:  Nature       Date:  1953-10-03       Impact factor: 49.962

2.  Combined treatment with regulatory T cells and vascularized bone marrow transplantation creates mixed chimerism and induces donor-specific tolerance to vascularized composite allografts without cytoreductive conditioning.

Authors:  Jeng-Yee Lin; Feng-Chou Tsai; Christopher Glenn Wallace; Wei-Chao Huang; Fu-Chan Wei; Shuen-Kuei Liao
Journal:  J Surg Res       Date:  2012-07-11       Impact factor: 2.192

3.  Isolation of regulatory T cells in the skin of a human hand-allograft, up to six years posttransplantation.

Authors:  Assia Eljaafari; Lionel Badet; Jean Kanitakis; Christophe Ferrand; Annie Farre; Palmina Petruzzo; Emmanuel Morelon; Muriel Dubosson; Pierre Tiberghien; Valérie Dubois; Xavier Martin; Pierre Miossec; Jean-Michel Dubernard
Journal:  Transplantation       Date:  2006-12-27       Impact factor: 4.939

4.  Optimizing chimerism level through bone marrow transplantation and irradiation to induce long-term tolerance to composite tissue allotransplantation.

Authors:  Jeng-Yee Lin; Feng-Chou Tsai; Christopher Glenn Wallace; Wei-Chao Huang; Fu-Chan Wei; Shuen-Kuei Liao
Journal:  J Surg Res       Date:  2012-03-17       Impact factor: 2.192

5.  Evidence that FoxP3+ regulatory T cells may play a role in promoting long-term acceptance of composite tissue allotransplants.

Authors:  Larry D Bozulic; Yujie Wen; Hong Xu; Suzanne T Ildstad
Journal:  Transplantation       Date:  2011-04-27       Impact factor: 4.939

6.  Treg-therapy allows mixed chimerism and transplantation tolerance without cytoreductive conditioning.

Authors:  N Pilat; U Baranyi; C Klaus; E Jaeckel; N Mpofu; F Wrba; D Golshayan; F Muehlbacher; T Wekerle
Journal:  Am J Transplant       Date:  2010-02-10       Impact factor: 8.086

7.  HLA-mismatched renal transplantation without maintenance immunosuppression.

Authors:  Tatsuo Kawai; A Benedict Cosimi; Thomas R Spitzer; Nina Tolkoff-Rubin; Manikkam Suthanthiran; Susan L Saidman; Juanita Shaffer; Frederic I Preffer; Ruchuang Ding; Vijay Sharma; Jay A Fishman; Bimalangshu Dey; Dicken S C Ko; Martin Hertl; Nelson B Goes; Waichi Wong; Winfred W Williams; Robert B Colvin; Megan Sykes; David H Sachs
Journal:  N Engl J Med       Date:  2008-01-24       Impact factor: 91.245

8.  Indoleamine 2,3-dioxygenase and foxp3 expression in skin rejection of human hand allografts.

Authors:  T Hautz; G Brandacher; B Zelger; H G Müller; A W P Lee; D Fuchs; R Margreiter; S Schneeberger
Journal:  Transplant Proc       Date:  2009-03       Impact factor: 1.066

9.  Mixed allogeneic chimerism in the rat. Donor-specific transplantation tolerance without chronic rejection for primarily vascularized cardiac allografts.

Authors:  Y L Colson; K Zadach; M Nalesnik; S T Ildstad
Journal:  Transplantation       Date:  1995-11-15       Impact factor: 4.939

10.  Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regimen.

Authors:  Y Sharabi; D H Sachs
Journal:  J Exp Med       Date:  1989-02-01       Impact factor: 14.307

  10 in total
  1 in total

1.  Vascularized Thymosternal Composite Tissue Allo- and Xenotransplantation in Nonhuman Primates: Initial Experience.

Authors:  Selin Sendil; Silviu C Diaconu; Natalie A O'Neill; Lars Burdorf; Ivan Tatarov; Dawn M Parsell; Agnes M Azimzadeh; Richard N Pierson; Arthur J Nam
Journal:  Plast Reconstr Surg Glob Open       Date:  2017-12-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.